期刊
PHARMACEUTICS
卷 13, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics13091390
关键词
protease activity; in situ zymography; Probody therapeutics; diagnostic; therapeutic; cancer
资金
- CytomX Therapeutics, Inc.
Proteases play crucial roles in physiological processes, with dysregulation linked to various pathologies, including cancer. A novel quantitative ex vivo zymography (QZ) technology has been developed to measure and classify protease activity in biological tissues, offering potential insights for diagnostic and therapeutic development in diseases characterized by dysregulated proteolysis such as cancer.
Proteases are involved in the control of numerous physiological processes, and their dysregulation has been identified in a wide range of pathologies, including cancer. Protease activity is normally tightly regulated post-translationally and therefore cannot be accurately estimated based on mRNA or protein expression alone. While several types of zymography approaches to estimate protease activity exist, there remains a need for a robust and reliable technique to measure protease activity in biological tissues. We present a novel quantitative ex vivo zymography (QZ) technology based on Probody(R) therapeutics (Pb-Tx), a novel class of protease-activated cancer therapeutics that contain a substrate linker cleavable by tumor-associated proteases. This approach enables the measurement and comparison of protease activity in biological tissues via the detection of Pb-Tx activation. By exploiting substrate specificity and selectivity, cataloguing and differentiating protease activities is possible, with further refinement achieved using protease-specific inhibitors. Using the QZ assay and human tumor xenografts, patient tumor tissues, and patient plasma, we characterized protease activity in preclinical and clinical samples. The QZ assay offers the potential to increase our understanding of protease activity in tissues and inform diagnostic and therapeutic development for diseases, such as cancer, that are characterized by dysregulated proteolysis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据